Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “SION”

1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,496
Index total 30,257
Page 28 / 63

Quick answer

This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,496 results for “SION” · 30,257 patents in full index Clear search

  1. US 10023650

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted
  2. US 10022450

    Regulation of specific spinal neurons regulating pain transmission via chimeric toxins

    The Regents of the University of California · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted
  3. US 10016388

    Ophthalmic lens, intraocular lens, and ophthalmic lens package having ophthalmic lens

    HON HAI PRECISION INDUSTRY CO., LTD. · Granted Jul 10, 2018 · Expires Jul 5, 2038

    granted
  4. US 10017543

    Prefusion RSV F proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 10, 2018 · Expires Jul 5, 2038

    granted
  5. US 10016463

    Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells

    United Therapeutics Corporation · Granted Jul 10, 2018 · Expires Jul 5, 2038

    granted
  6. US 10016461

    Apparatus and process for growing a heart valve in three-dimensions

    The Regents of the University of California · Granted Jul 10, 2018 · Expires Jul 5, 2038

    granted
  7. US 10006052

    Laglidadg homing endonuclease cleaving the C-C chemokine receptor type-5 (CCR5) gene and uses thereof

    PRECISION GENOME ENGINEERING, INC. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  8. US 10006025

    Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin

    Arrowhead Pharmaceuticals, Inc. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  9. US 10004699

    Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse

    Acurx Pharmaceuticals, Inc. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  10. US 10000746

    LAGLIDADG homing endonuclease cleaving the T cell receptor alpha gene and uses thereof

    PRECISION GENOME ENGINEERING, INC. · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted
  11. US 9993502

    Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

    Precision BioSciences, Inc. · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  12. US 9994855

    Compositions and methods for modulating growth hormone receptor expression

    Ionis Pharmaceuticals, Inc. · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  13. US 9993501

    Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

    Precision BioSciences, Inc. · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  14. US 9988630

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  15. US 9980931

    Use of glycyl glutamine against depression

    Uludag Universitesi Teknoloji Transfer Ofisi Ticaret Ve Sanayi Anonim Suirketi · Granted May 29, 2018 · Expires May 24, 2038

    granted
  16. US 9974742

    Emulsion formulations of an NK-1 receptor antagonist and uses thereof

    Heron Therapeutics, Inc. · Granted May 22, 2018 · Expires May 17, 2038

    granted
  17. US 9974794

    Emulsion formulations of aprepitant

    Heron Therapeutics, Inc. · Granted May 22, 2018 · Expires May 17, 2038

    granted
  18. US 9976123

    Cellular seeding and co-culture of a three dimensional fibroblast construct

    Arizona Board of Regents on Behalf of the University of Arizona · Granted May 22, 2018 · Expires May 17, 2038

    granted
  19. US 9975952

    Antibody fragments, compositions and uses thereof

    METIS PRECISION MEDICINE SB S.R.L. · Granted May 22, 2018 · Expires May 17, 2038

    granted
  20. US 9976141

    Compositions and methods for inhibiting gene expression of Hif2alpha

    Arrowhead Pharmaceuticals, Inc. · Granted May 22, 2018 · Expires May 17, 2038

    granted
  21. US 9975926

    Methods of making and using vaccines utilizing minicircle DNA expression vectors for production of foot-and-mouth-disease virus proteins and virus-like particles

    The United States of America, as represented by the Secretary of Homeland Security · Granted May 22, 2018 · Expires May 17, 2038

    granted
  22. US 9976138

    Methods and compounds useful in conditions related to repeat expansion

    Ionis Pharmaceuticals, Inc. · Granted May 22, 2018 · Expires May 17, 2038

    granted
  23. US 9977021

    CD127 expression inversely correlates with FoxP3 and suppressive function of CD4+ tregs

    The Regents of the University of California · Granted May 22, 2018 · Expires May 17, 2038

    granted
  24. US 9974793

    Emulsion formulations of aprepitant

    Heron Therapeutics, Inc. · Granted May 22, 2018 · Expires May 17, 2038

    granted